Clinical Trial Update: Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

View source ↗

Summary

The update describes a completed clinical trial evaluating novel biomarkers that may predict outcomes in patients with Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Clostridium Difficile Infection | Status: COMPLETED